Protective effect of chronic treatment with a continuous erythropoietin receptor activator on CKD-induced myocardial intolerance to ischemia/reperfusion injury is lost by use of its excessive dose.
Protective effect of chronic treatment with a continuous erythropoietin receptor activator on CKD-induced myocardial intolerance to ischemia/reperfusion injury is lost by use of its excessive dose.
复制标题
使用连续促红细胞生成素受体激活剂长期治疗对 CKD 诱导的心肌缺血/再灌注损伤不耐受的保护作用会因使用过量而丧失。
DOI：
--
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Tetsuji Miura.
中科院分区：
文献类型：
--
作者：
Tatsuya Sato;Toshiyuki Yano;Keitaro Nishizawa;Yukishige Kimura;Takayuki Miki;Masaya Tanno;Atsushi Kuno;Michinori Hirata;Ryohei Kawasaki;Tetsuji Miura.
